← Browse by Condition
Medical Condition
epstein barr virus infections
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 1, Phase 2
NCT05183490 Phase 1
Recruiting
R-MVST Cells for Treatment of Viral Infections
Enrollment
36 pts
Location
United States
Sponsor
Columbia University
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Enrollment
365 pts
Location
United States, Canad...
Sponsor
Marengo Therapeutics, Inc.